ODAC Recommends Approval of Pegylated Interferon Alfa-2b for Malignant Melanoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 11, p. 928
- Publication type:
- Article
Works matching DE "SCHERING-Plough Corp."
Results: 105
1
2
Noxafil Approved for Prevention of Invasive Aspergillus Infections.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 11, p. 1451
- Publication type:
- Article
3
Schering-Plough's Search for Biomarkers.
- Published in:
- Bio-IT World, 2009, v. 8, n. 6, p. 44
- By:
- Publication type:
- Article
4
Marketing Research in the Courtroom.
- Published in:
- 2002
- By:
- Publication type:
- Case Study
5
Janssen takes over distribution.
- Published in:
- Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 58
- Publication type:
- Article
6
Medicines Australia clamps down on code breakers.
- Published in:
- Australian Journal of Pharmacy, 2011, v. 92, n. 1089, p. 50
- Publication type:
- Article
7
OTC PRODUCTS.
- Published in:
- 2009
- Publication type:
- Product Review
8
Merck/Schering Plough deal.
- Published in:
- Australian Journal of Pharmacy, 2009, v. 90, n. 1067, p. 57
- Publication type:
- Article
9
Proudly in the business of professional healthcare.
- Published in:
- Australian Journal of Pharmacy, 2009, v. 90, n. 1067, p. 14
- Publication type:
- Article
10
In re K-Dur Antitrust Litigation--Reverse Payments : Against Prices, Purchasers, and Policy.
- Published in:
- Tulane Journal of Technology & Intellectual Property, 2012, v. 15, p. 293
- By:
- Publication type:
- Article
11
Top 10 pharma firings of 2009.
- Published in:
- Nature Medicine, 2010, v. 16, n. 1, p. 6, doi. 10.1038/nm0110-6b
- Publication type:
- Article
12
Harsh spotlight falls on Vytorin.
- Published in:
- Nature Medicine, 2008, v. 14, n. 5, p. 471, doi. 10.1038/nm0508-471c
- By:
- Publication type:
- Article
13
New antifungal approved.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 21, p. 2030, doi. 10.2146/news060015
- By:
- Publication type:
- Article
14
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 21, p. 2030
- Publication type:
- Article
15
Flutamide helps treat B2- to D2-staged PCa.
- Published in:
- Urology Times, 1996, v. 24, n. 8, p. 31
- Publication type:
- Article
16
US case law developments in 2005.
- Published in:
- Journal of Generic Medicines, 2006, v. 3, n. 3, p. 237, doi. 10.1057/palgrave.jgm.4940125
- By:
- Publication type:
- Article
17
Landmark anti-trust decision in brand-generic agreements.
- Published in:
- Journal of Generic Medicines, 2005, v. 2, n. 4, p. 365, doi. 10.1057/palgrave.jgm.4940090
- Publication type:
- Article
18
Andrx v Elan: The Eleventh Circuit applies its Schering-Plough v FTC decision.
- Published in:
- Journal of Generic Medicines, 2006, v. 3, n. 2, p. 147, doi. 10.1057/palgrave.jgm.4940112
- By:
- Publication type:
- Article
19
Schering-Plough Opens Innovative Research & Development Facility in Biopolis.
- Published in:
- Innovation, 2009, v. 9, n. 1, p. 10
- Publication type:
- Article
20
A Boost to Singapore's Translational Research.
- Published in:
- 2009
- Publication type:
- Interview
21
The Eighth Annual Residents' Contest.
- Published in:
- 1987
- By:
- Publication type:
- Editorial
22
The Seventh Annual Residents' Contest.
- Published in:
- 1986
- By:
- Publication type:
- Editorial
23
The Schering Soft Tissue Workshop Series 1984-1985.
- Published in:
- Journal of Dermatologic Surgery & Oncology, 1984, v. 10, n. 12, p. 999
- Publication type:
- Article
24
Schering-Plough--Failing to Apply the IRS's Position on Conduits for Purposes of Code Sec. 956.
- Published in:
- International Tax Journal, 2010, v. 36, n. 4, p. 47
- By:
- Publication type:
- Article
25
A Note From the Editor-in-Chief.
- Published in:
- International Tax Journal, 2010, v. 36, n. 1, p. 3
- By:
- Publication type:
- Article
26
Schering-Plough: IRS Trains Its Business Purpose and Economic Substance Weaponry on Deemed Repatriation Strategy.
- Published in:
- International Tax Journal, 2009, v. 35, n. 6, p. 35
- By:
- Publication type:
- Article
27
Recent Developments in Patent Law: Decisions by the U.S. Court of Appeals for the Federal Circuit.
- Published in:
- Texas Intellectual Property Law Journal, 2004, v. 12, n. 3, p. 497
- By:
- Publication type:
- Article
28
Alleged Unethical Behaviors and Schering-Plough.
- Published in:
- Strategic Finance, 2001, v. 83, n. 1, p. 18
- By:
- Publication type:
- Article
29
Schering-Plough acquires Intervet.
- Published in:
- Veterinary Record: Journal of the British Veterinary Association, 2007, v. 160, n. 13, p. 421, doi. 10.1136/vr.160.13.421-a
- Publication type:
- Article
30
Merck wields the axe: 16,000 jobs go.
- Published in:
- Chemistry & Industry, 2010, n. 14, p. 6
- By:
- Publication type:
- Article
31
Business digest.
- Published in:
- Chemistry & Industry, 2009, n. 16, p. 13
- By:
- Publication type:
- Article
32
Merck & Co in mega-deal with Schering-Plough.
- Published in:
- Chemistry & Industry, 2009, n. 6, p. 5
- Publication type:
- Article
33
Pharma has good start to 2008.
- Published in:
- Chemistry & Industry, 2008, n. 9, p. 8
- By:
- Publication type:
- Article
34
Analysing performance.
- Published in:
- Chemistry & Industry, 2007, n. 22, p. 12
- By:
- Publication type:
- Article
35
More heartache for statins.
- Published in:
- Chemistry & Industry, 2007, n. 7, p. 7
- By:
- Publication type:
- Article
36
Schering-Plough set to acquire Organon.
- Published in:
- Chemistry & Industry, 2007, n. 6, p. 9
- By:
- Publication type:
- Article
37
news.
- Published in:
- Chemistry & Industry, 2006, n. 18, p. 9
- By:
- Publication type:
- Article
38
Bayer ties up with Schering-Plough in bid to revive pharma.
- Published in:
- Chemistry & Industry, 2004, n. 18, p. 6
- By:
- Publication type:
- Article
39
Schering pays $500 000 over pharma charges.
- Published in:
- Chemistry & Industry, 2004, n. 12, p. 7
- Publication type:
- Article
40
Movers & Shakers.
- Published in:
- Chemistry & Industry, 2004, n. 10, p. 34
- Publication type:
- Article
41
Ex-CEO Kogan fined heavily for earning prospects 'implications.'.
- Published in:
- Chemistry & Industry, 2003, n. 19, p. 9
- Publication type:
- Article
42
Pharma firms weather 2002 storm.
- Published in:
- Chemistry & Industry, 2003, n. 3, p. 5
- Publication type:
- Article
43
Schering-Plough Issues Drug Warning About Temodar.
- Published in:
- Clinical Journal of Oncology Nursing, 2005, v. 9, n. 1, p. 27
- Publication type:
- Article
44
ROBERT E. WATERMAN.
- Published in:
- BioScience, 1966, v. 16, n. 10, p. 682, doi. 10.1093/bioscience/16.10.682-a
- Publication type:
- Article
45
Clinical Trials News.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 2, p. 18
- Publication type:
- Article
46
Clinical Trials News.
- Published in:
- Applied Clinical Trials, 2004, v. 13, n. 8, p. 15
- Publication type:
- Article
47
News Update.
- Published in:
- Applied Clinical Trials, 2001, v. 10, n. 3, p. 18
- Publication type:
- Article
48
PsychRx.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 9, p. 10
- Publication type:
- Article
49
SCHERING-PLOUGH SUBMITS RESPONSE TO FDA FOR SAPHRIS (ASENAPINE) IN THE ACUTE TREATMENT OF BOTH SCHIZOPHRENIA AND BIPOLAR I DISORDER.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 13
- Publication type:
- Article
50
Asenapine.
- Published in:
- 2011
- Publication type:
- Product Review